Cangene announces potential new treatment for hospital-acquired infections
According to the company, unlike antibiotics that directly inhibit bacterial growth or destroy the cells, Cangene's peptides may function by enhancing the patient's own immune system so that it can clear an infection. Treatment with the peptides was highly effective in reducing both the number of S. aureus cells found at the wound site and the associated inflammation they cause. These data suggest a novel approach for treating and possibly preventing staphylococcal wound infections in the clinical setting.
Original publication: Antimicrobial Agents and Chemotherapy 2006 Nov; 50(11):3856-60.
Most read news
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.